Immuneering Corp (IMRX) is the 141st largest of 261 Pharmaceuticals companies by market capitalisation, at 313.46 Mn, behind Sionna Therapeutics, Inc. at 318.75 Mn. The table below compares all 261 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 664.53 Bn | 31.59 | 6.79 | 643.77 Bn |
| 2 | ABBV | AbbVie Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 455.08 Bn | 72.05 | 7.07 | 448.52 Bn |
| 3 | MRK | Merck & Co., Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 372.83 Bn | 117.65 | 5.60 | 365.69 Bn |
| 4 | NVS | Novartis Ag | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 310.82 Bn | 13.82 | 4.52 | 303.13 Bn |
| 5 | PFE | Pfizer Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 162.34 Bn | 37.17 | 2.55 | 150.64 Bn |
| 6 | SNY | Sanofi | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 53.92 Bn | 11.57 | 1.01 | 46.54 Bn |
| 7 | RVMD | Revolution Medicines, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 43.94 Bn | -24.85 | — | 43.94 Bn |
| 8 | ONC | BeOne Medicines Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 40.07 Bn | 61.10 | 6.54 | 34.97 Bn |
| 9 | INCY | Incyte Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.46 Bn | 15.79 | 4.38 | 20.93 Bn |
| 10 | UTHR | UNITED THERAPEUTICS Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 20.87 Bn | 15.92 | 6.62 | 18.21 Bn |
| 11 | NBIX | Neurocrine Biosciences Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.86 Bn | 22.48 | 4.70 | 15.47 Bn |
| 12 | JAZZ | Jazz Pharmaceuticals plc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.64 Bn | 16.62 | 3.40 | 14.02 Bn |
| 13 | EXEL | Exelixis, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.72 Bn | 17.10 | 6.04 | 13.88 Bn |
| 14 | CORT | Corcept Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.61 Bn | 214.18 | 13.97 | 11.30 Bn |
| 15 | KYMR | Kymera Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.54 Bn | -38.51 | 109.89 | 10.85 Bn |
| 16 | AXSM | Axsome Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.70 Bn | -69.61 | 13.78 | 10.38 Bn |
| 17 | GPCR | Structure Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.26 Bn | -54.55 | — | 10.26 Bn |
| 18 | NUVL | Nuvalent, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 19 | CYTK | Cytokinetics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.65 Bn | -13.16 | 142.63 | 8.49 Bn |
| 20 | CRNX | Crinetics Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 21 | ALKS | Alkermes plc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.77 Bn | 117.49 | 4.66 | 7.11 Bn |
| 22 | TVTX | Travere Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.16 Bn | -141.65 | 10.41 | 6.16 Bn |
| 23 | BLTE | Belite Bio, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.12 Bn | -79.42 | — | 6.12 Bn |
| 24 | LQDA | Liquidia Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.06 Bn | 43.76 | 13.45 | 5.78 Bn |
| 25 | AMRN | Amarin Corp Plc\Uk | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.71 Bn | -210.34 | 30.64 | 5.39 Bn |
| 26 | ACAD | Acadia Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.81 Bn | 12.63 | 4.22 | 3.85 Bn |
| 27 | EWTX | Edgewise Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.54 Bn | -23.01 | — | 4.54 Bn |
| 28 | DFTX | Definium Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.20 Bn | -11.87 | — | 4.20 Bn |
| 29 | INDV | Indivior Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.16 Bn | 11.73 | 3.13 | 3.94 Bn |
| 30 | MANE | Veradermics, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.00 Bn | -46.49 | — | 4.00 Bn |
| 31 | ELVN | Enliven Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.94 Bn | -46.83 | — | 3.94 Bn |
| 32 | CPRX | CATALYST PHARMACEUTICALS, INC. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 33 | OGN | Organon & Co. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.62 Bn | 17.31 | 0.59 | 2.49 Bn |
| 34 | TARS | Tarsus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.61 Bn | -76.85 | 5.95 | 3.16 Bn |
| 35 | NAMS | NewAmsterdam Pharma Co N.V. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.15 Bn | -12.15 | 442.82 | 3.15 Bn |
| 36 | TRVI | Trevi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.65 Bn | -62.93 | — | 2.65 Bn |
| 37 | TAK | Takeda Pharmaceutical Co Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.65 Bn | 4.62 | 0.06 | -3.15 Bn |
| 38 | SUPN | Supernus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.55 Bn | -29.96 | 3.24 | 2.18 Bn |
| 39 | HRMY | Harmony Biosciences Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.42 Bn | 13.56 | 2.52 | 1.61 Bn |
| 40 | NUVB | Nuvation Bio Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.36 Bn | -21.85 | 13.91 | 2.36 Bn |
| 41 | MLYS | Mineralys Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.35 Bn | -6.73 | — | 2.35 Bn |
| 42 | PVLA | Palvella Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.23 Bn | -42.12 | — | 1.92 Bn |
| 43 | AUPH | Aurinia Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.09 Bn | 6.66 | 6.72 | 1.65 Bn |
| 44 | ETON | Eton Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.62 Bn | 170.01 | 16.19 | 1.60 Bn |
| 45 | INVA | Innoviva, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.56 Bn | 7.95 | 3.03 | 0.98 Bn |
| 46 | XERS | Xeris Biopharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.47 Bn | -85.43 | 4.37 | 1.34 Bn |
| 47 | LBRX | Lb Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.44 Bn | -23.83 | — | 1.44 Bn |
| 48 | HROW | Harrow, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -42.55 | 5.16 | 1.34 Bn |
| 49 | OPK | Opko Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.20 Bn | -31.69 | 2.04 | 0.90 Bn |
| 50 | KURA | Kura Oncology, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.16 Bn | -4.88 | 15.04 | 1.16 Bn |
| 51 | OLMA | Olema Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.12 Bn | -5.46 | — | 1.12 Bn |
| 52 | PCRX | Pacira BioSciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.04 Bn | 71.22 | 1.40 | 0.79 Bn |
| 53 | LXRX | Lexicon Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -15.48 | 23.48 | 0.78 Bn |
| 54 | SGP | SpyGlass Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.96 Bn | -48.80 | — | 0.96 Bn |
| 55 | DSGN | Design Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -11.66 | — | 0.74 Bn |
| 56 | IVA | Inventiva S.A. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.89 Bn | 9.70 | 179.22 | 0.89 Bn |
| 57 | VSTM | Verastem, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.79 Bn | -6.85 | 9.02 | 0.65 Bn |
| 58 | COLL | Collegium Pharmaceutical, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.78 Bn | 16.33 | 0.97 | 0.63 Bn |
| 59 | PHAT | Phathom Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.75 Bn | -7.62 | 3.12 | 0.56 Bn |
| 60 | ZVRA | Zevra Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.74 Bn | 12.71 | 5.44 | 0.52 Bn |
| 61 | AQST | Aquestive Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.68 Bn | -8.64 | 12.50 | 0.68 Bn |
| 62 | CRMD | CorMedix Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.66 Bn | 5.24 | 1.76 | 0.40 Bn |
| 63 | GYRE | Gyre Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.65 Bn | -35.26 | 5.45 | 0.59 Bn |
| 64 | MPLT | MapLight Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.61 Bn | -3.03 | — | 0.61 Bn |
| 65 | EOLS | Evolus, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -17.36 | 1.88 | 0.55 Bn |
| 66 | NVCT | Nuvectis Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.59 Bn | -19.39 | — | 0.59 Bn |
| 67 | SPRY | ARS Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.56 Bn | -2.51 | 4.75 | 0.41 Bn |
| 68 | OVID | Ovid Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.55 Bn | -15.86 | 345.51 | 0.43 Bn |
| 69 | XFOR | X4 Pharmaceuticals, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.51 Bn | -5.65 | 32.13 | 0.31 Bn |
| 70 | IKT | Inhibikase Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -6.68 | — | 0.28 Bn |
| 71 | PALI | Palisade Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -12.22 | 862.44 | 0.31 Bn |
| 72 | VTVT | vTv Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -86.59 | 11.18 | 0.41 Bn |
| 73 | ACHV | Achieve Life Sciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.36 Bn | — | — | 0.36 Bn |
| 74 | VNDA | Vanda Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.18 | 1.50 | 0.15 Bn |
| 75 | EBS | Emergent BioSolutions Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.81 | 0.42 | 0.18 Bn |
| 76 | SION | Sionna Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -3.27 | — | 0.32 Bn |
| 77 | IMRX | Immuneering Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -5.34 | — | 0.31 Bn |
| 78 | TTRX | Turn Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -38.26 | — | 0.29 Bn |
| 79 | FULC | Fulcrum Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.29 | — | 0.29 Bn |
| 80 | ZNTL | Zentalis Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -2.08 | — | 0.29 Bn |
| 81 | CELG-RI | Bristol Myers Squibb Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | 0.03 | 0.01 | -10.81 Bn |
| 82 | AKBA | Akebia Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -8.69 | 1.18 | 0.10 Bn |
| 83 | SIGA | Siga Technologies Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | — | — | 0.07 Bn |
| 84 | TNXP | Tonix Pharmaceuticals Holding Corp. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.37 | 7.50 | 0.22 Bn |
| 85 | NERV | Minerva Neurosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -32.92 | — | 0.22 Bn |
| 86 | DERM | Journey Medical Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -59.03 | 3.17 | 0.19 Bn |
| 87 | ACOG | Alpha Cognition Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.36 | 15.09 | 0.16 Bn |
| 88 | SLGL | Sol-Gel Technologies Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -18.73 | 109.43 | 0.15 Bn |
| 89 | MCUJF | Medicure Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -36.51 | 8.32 | 0.19 Bn |
| 90 | CRDL | Cardiol Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -7.24 | — | 0.17 Bn |
| 91 | LONA | LeonaBio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -1.48 | — | 0.13 Bn |
| 92 | LENZ | LENZ Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -1.37 | 8.24 | 0.18 Bn |
| 93 | MENS | Jyong Biotech Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -44.35 | — | 0.18 Bn |
| 94 | BMEA | Biomea Fusion, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -2.54 | — | 0.14 Bn |
| 95 | NTHI | Neonc Technologies Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -2.82 | — | 0.13 Bn |
| 96 | AARD | Aardvark Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -1.74 | — | 0.05 Bn |
| 97 | VANI | Vivani Medical, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -4.45 | — | 0.10 Bn |
| 98 | VRCA | Verrica Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -3.64 | 3.78 | 0.10 Bn |
| 99 | CPIX | Cumberland Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -9.33 | 3.22 | 0.10 Bn |
| 100 | CGTX | Cognition Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.54 | — | 0.09 Bn |
| 101 | RGC | Regencell Bioscience Holdings Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | — | — | 0.09 Bn |
| 102 | PTHS | Pelthos Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -0.78 | 1.62 | 0.06 Bn |
| 103 | TENX | Tenax Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -1.28 | — | 0.08 Bn |
| 104 | MNOV | Medicinova Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -6.79 | 89.30 | 0.08 Bn |
| 105 | PMVP | PMV Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.15 | — | -0.01 Bn |
| 106 | PLRX | Pliant Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -0.75 | — | 0.07 Bn |
| 107 | CING | Cingulate Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -3.12 | — | 0.07 Bn |
| 108 | BOLD | Boundless Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -1.01 | — | 0.06 Bn |
| 109 | VERU | Veru Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 124.74 | — | 0.04 Bn |
| 110 | GOSS | Gossamer Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.32 | 1.03 | 0.00 Bn |
| 111 | ANVS | Annovis Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -1.10 | — | 0.05 Bn |
| 112 | KPTI | Karyopharm Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.26 | 0.35 | 0.05 Bn |
| 113 | CLNN | Clene Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -1.41 | 224.79 | 0.05 Bn |
| 114 | APRE | Aprea Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.42 | — | 0.04 Bn |
| 115 | IXHL | Incannex Healthcare Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.82 | — | 0.04 Bn |
| 116 | SCLX | Scilex Holding Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 1.18 | -0.08 Bn |
| 117 | ACTU | Actuate Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.80 | — | 0.04 Bn |
| 118 | GRCE | Grace Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.81 | — | 0.04 Bn |
| 119 | CPHI | China Pharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -7.56 | 8.65 | 0.03 Bn |
| 120 | UG | United Guardian Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 14.43 | 2.91 | 0.02 Bn |
| 121 | NSRX | Nasus Pharma Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -5.64 | — | 0.03 Bn |
| 122 | CRVO | CervoMed Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.87 | 79.47 | 0.03 Bn |
| 123 | BYSI | BeyondSpring Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.04 | — | 0.03 Bn |
| 124 | TXMD | TherapeuticsMD, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -137.64 | 7.79 | 0.02 Bn |
| 125 | YARW | Yarrow Bioscience, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.21 | 50.42 | 0.00 Bn |
| 126 | AYTU | Aytu Biopharma, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.82 | 0.44 | 0.00 Bn |
| 127 | ALLR | Allarity Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.87 | 906.91 | 0.02 Bn |
| 128 | ATOS | Atossa Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.74 | — | 0.02 Bn |
| 129 | BFRI | Biofrontera Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.29 | 0.45 | 0.02 Bn |
| 130 | MIRA | Mira Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.57 | — | 0.01 Bn |
| 131 | TVRD | Tvardi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.66 | — | 0.02 Bn |
| 132 | KPRX | Kiora Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.46 | — | 0.02 Bn |
| 133 | CTXR | Citius Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.34 | 2.22 | 0.02 Bn |
| 134 | INTI | Inhibitor Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.72 | — | 0.02 Bn |
| 135 | ANEB | Anebulo Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.37 | — | 0.01 Bn |
| 136 | CALC | CalciMedica, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.35 | -8.71 | -0.01 Bn |
| 137 | CURX | Curanex Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.92 | — | 0.00 Bn |
| 138 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.75 | — | 0.01 Bn |
| 139 | ADXN | Addex Therapeutics Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.05 | — | 0.01 Bn |
| 140 | ACXP | Acurx Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.79 | — | 0.01 Bn |
| 141 | TRAW | Traws Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.34 | — | 0.00 Bn |
| 142 | PCSA | Processa Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.41 | — | 0.01 Bn |
| 143 | PULM | Pulmatrix, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.31 | — | 0.01 Bn |
| 144 | TCRT | Alaunos Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.99 | 1,333.38 | 0.00 Bn |
| 145 | CVKD | Cadrenal Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.31 | — | 0.00 Bn |
| 146 | BICX | BioCorRx Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.64 | 6.70 | 0.00 Bn |
| 147 | CASIF | CASI Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | 0.12 | 0.00 Bn |
| 148 | SKVI | Skinvisible, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -2.25 | 116.18 | 0.00 Bn |
| 149 | OGEN | Oragenics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.22 | — | 0.00 Bn |
| 150 | CANF | Can-Fite BioPharma Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.21 | 5.02 | -0.01 Bn |
| 151 | UPC | Universe Pharmaceuticals INC | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -1,490.23 Bn |
| 152 | MTNB | Matinas BioPharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.16 | — | 0.00 Bn |
| 153 | ENSC | Ensysce Biosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 154 | SPRC | SciSparc Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.05 | 0.77 | 0.00 Bn |
| 155 | NCEL | NewcelX Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.06 | — | 0.00 Bn |
| 156 | JAGX | Jaguar Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | 0.02 | -0.01 Bn |
| 157 | GLMD | Galmed Pharmaceuticals Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -0.01 Bn |
| 158 | CDT | CDT Equity Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | — | 0.00 Bn |
| 159 | GCAN | Trafalgar International, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.77 | — | 0.00 Bn |
| 160 | SXTC | China SXT Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | 0.03 | -0.03 Bn |
| 161 | CMND | Clearmind Medicine Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | -0.01 Bn |
| 162 | TMO | Thermo Fisher Scientific Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 226.37 Bn | 32.15 | 4.89 | 222.31 Bn |
| 163 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 186.76 Bn | -64.51 | 6.13 | 183.58 Bn |
| 164 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 140.06 Bn | 31.79 | 11.13 | 132.21 Bn |
| 165 | IQV | Iqvia Holdings Inc. | secondary | H-11 | Pharma Services | HG-03 | 44.24 Bn | 33.51 | 2.60 | 42.16 Bn |
| 166 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.75 Bn | 61.42 | 2.47 | 39.09 Bn |
| 167 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 35.01 Bn | 29.40 | 3.25 | 33.56 Bn |
| 168 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 31.30 Bn | 15.26 | 1.47 | 29.19 Bn |
| 169 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.49 Bn | -31.40 | 24.16 | 26.33 Bn |
| 170 | LH | Labcorp Holdings Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 26.93 Bn | 26.83 | 1.88 | 26.78 Bn |
| 171 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 24.78 Bn | -16.70 | 2,268.64 | 24.78 Bn |
| 172 | GH | Guardant Health, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 20.80 Bn | -45.87 | 17.58 | 19.74 Bn |
| 173 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.69 Bn | -47.94 | 1.34 | 18.80 Bn |
| 174 | LDOS | Leidos Holdings, Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 16.80 Bn | 12.05 | 0.95 | 16.06 Bn |
| 175 | MEDP | Medpace Holdings, Inc. | secondary | H-11 | Pharma Services | HG-03 | 16.67 Bn | 33.92 | 5.99 | 16.17 Bn |
| 176 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.58 Bn | 40.94 | 4.15 | 13.97 Bn |
| 177 | CRL | Charles River Laboratories International, Inc. | secondary | H-11 | Pharma Services | HG-03 | 13.90 Bn | -58.50 | 3.48 | 13.71 Bn |
| 178 | ICLR | Icon Plc | secondary | H-11 | Pharma Services | HG-03 | 12.80 Bn | 16.45 | 1.55 | 12.80 Bn |
| 179 | DVA | Davita Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 11.82 Bn | 10.15 | 0.84 | 11.13 Bn |
| 180 | TEM | Tempus AI, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 11.65 Bn | -46.90 | 8.14 | 10.84 Bn |
| 181 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.38 Bn | -65.88 | 16.93 | 10.26 Bn |
| 182 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.31 Bn | -27.03 | — | 9.55 Bn |
| 183 | RDY | Dr Reddys Laboratories Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 9.93 Bn | 786.78 | 2.71 | 9.76 Bn |
| 184 | TWST | Twist Bioscience Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 7.83 Bn | -57.26 | 18.13 | 7.66 Bn |
| 185 | CAI | Caris Life Sciences, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 7.01 Bn | 66.65 | 7.08 | 6.21 Bn |
| 186 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.53 Bn | -729.45 | 4,693.23 | 6.53 Bn |
| 187 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.43 Bn | -39.42 | 1.21 | 6.05 Bn |
| 188 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.62 Bn | 26.12 | 1.80 | 5.50 Bn |
| 189 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.07 Bn | -17.67 | — | 5.07 Bn |
| 190 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.18 Bn | -8.18 | 1,160.58 | 4.18 Bn |
| 191 | ADPT | Adaptive Biotechnologies Corp | secondary | H-17 | Healthcare Providers | HG-04 | 3.86 Bn | -95.94 | 12.54 | 3.52 Bn |
| 192 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.74 Bn | -8.14 | 31.99 | 3.04 Bn |
| 193 | ABCL | AbCellera Biologics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.49 Bn | -21.21 | 52.78 | 3.49 Bn |
| 194 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.05 Bn | -11.27 | 593.06 | 2.53 Bn |
| 195 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.89 Bn | -15.35 | 6.43 | 2.18 Bn |
| 196 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.85 Bn | -8.34 | 77.41 | 2.40 Bn |
| 197 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.64 Bn | -81.24 | — | 2.64 Bn |
| 198 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.54 Bn | -6.61 | 4.76 | 2.19 Bn |
| 199 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.53 Bn | -21.31 | 1.93 | 2.43 Bn |
| 200 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.49 Bn | -2.28 | 0.23 | 0.65 Bn |
| 201 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.33 Bn | -3.97 | — | 2.06 Bn |
| 202 | NEO | Neogenomics Inc | secondary | H-17 | Healthcare Providers | HG-04 | 2.23 Bn | -43.00 | 2.91 | 2.09 Bn |
| 203 | FMS | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 2.20 Bn | 1.84 | 0.08 | 0.37 Bn |
| 204 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.08 Bn | -4.99 | 2,076.40 | 2.08 Bn |
| 205 | FTRE | Fortrea Holdings Inc. | secondary | H-11 | Pharma Services | HG-03 | 1.73 Bn | -20.35 | 0.65 | 1.57 Bn |
| 206 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.61 Bn | -3.48 | 2.24 | 1.31 Bn |
| 207 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.57 Bn | -9.11 | 20.12 | 1.29 Bn |
| 208 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.51 Bn | 14.01 | 1.55 | 1.15 Bn |
| 209 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.46 Bn | -8.92 | — | 1.46 Bn |
| 210 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | 80.99 | 35.98 | 1.38 Bn |
| 211 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.34 Bn | -28.11 | — | 1.13 Bn |
| 212 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.01 Bn | -73.00 | — | 0.96 Bn |
| 213 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.85 Bn | -10.64 | 103.07 | 0.85 Bn |
| 214 | EVO | Evotec SE | secondary | H-11 | Pharma Services | HG-03 | 0.66 Bn | — | — | 0.23 Bn |
| 215 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -358,376.91 | — | 0.34 Bn |
| 216 | STLN | Starling Oncology, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.61 Bn | -20.08 | 1.04 | 0.57 Bn |
| 217 | OABI | OmniAb, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.59 Bn | -13.42 | 15.45 | 0.54 Bn |
| 218 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.59 Bn | 1,185.74 | 6.14 | 0.49 Bn |
| 219 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.53 Bn | -7.85 | 23.61 | 0.25 Bn |
| 220 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.48 Bn | -10.27 | 78.36 | 0.25 Bn |
| 221 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -4.62 | 43.76 | 0.24 Bn |
| 222 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -4.46 | 43.93 | 0.34 Bn |
| 223 | DNA | Ginkgo Bioworks Holdings, Inc. | secondary | H-11 | Pharma Services | HG-03 | 0.43 Bn | -1.47 | 3.83 | 0.34 Bn |
| 224 | CLPT | ClearPoint Neuro, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.42 Bn | -14.39 | 9.92 | 0.39 Bn |
| 225 | WDH | Waterdrop Inc. | secondary | F-16 | Insurance | FG-04 | 0.39 Bn | 4.95 | 0.61 | 0.26 Bn |
| 226 | SWKHL | SWK Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -333.02 | 7.49 | 0.27 Bn |
| 227 | BDSX | Biodesix Inc | secondary | H-17 | Healthcare Providers | HG-04 | 0.27 Bn | -9.43 | 2.63 | 0.24 Bn |
| 228 | YDES | YD Bio Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.24 Bn | -19.42 | 287.04 | 0.24 Bn |
| 229 | FTH | Faeth Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.14 | — | 0.22 Bn |
| 230 | AGPU | Axe Compute Inc. | secondary | T-44 | Cloud Computing | TG-07 | 0.20 Bn | -7.97 | — | 0.18 Bn |
| 231 | XGN | Exagen Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.18 Bn | -9.52 | 2.53 | 0.16 Bn |
| 232 | TNYA | Tenaya Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.46 | 112.94 | 0.15 Bn |
| 233 | KRMD | KORU Medical Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.15 Bn | -63.62 | 3.31 | 0.14 Bn |
| 234 | IFRX | InflaRx N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -3.68 | 1,882.13 | -0.04 Bn |
| 235 | IMDX | Insight Molecular Diagnostics Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.15 Bn | -2.70 | 87.80 | 0.13 Bn |
| 236 | SPRB | Spruce Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -2.90 | — | 0.14 Bn |
| 237 | MXCT | Maxcyte, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.14 Bn | -3.85 | 4.42 | 0.14 Bn |
| 238 | BNR | Burning Rock Biotech Ltd | secondary | H-17 | Healthcare Providers | HG-04 | 0.10 Bn | -11.34 | 1.25 | 0.03 Bn |
| 239 | FBIO | Fortress Biotech, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 10.31 | 1.25 | -0.11 Bn |
| 240 | PYPD | PolyPid Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 2.71 | — | 0.08 Bn |
| 241 | AIFC | AI Financial Corp | secondary | T-54 | Fintech | TG-09 | 0.08 Bn | -0.09 | 3.75 | 0.07 Bn |
| 242 | CSBR | Champions Oncology, Inc. | secondary | H-11 | Pharma Services | HG-03 | 0.07 Bn | -61.57 | 1.22 | 0.07 Bn |
| 243 | NTRB | NutriBand Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -2.29 | 37.92 | 0.06 Bn |
| 244 | XBIT | XBiotech Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.62 | — | 0.07 Bn |
| 245 | HYFT | MindWalk Holdings Corp. | secondary | H-11 | Pharma Services | HG-03 | 0.06 Bn | -10.23 | 5.54 | 0.05 Bn |
| 246 | PTN | Palatin Technologies Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -8.22 | 4.00 | 0.05 Bn |
| 247 | APLM | Apollomics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.67 | 4.72 | 0.04 Bn |
| 248 | BETRF | BetterLife Pharma Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -21.82 | — | 0.03 Bn |
| 249 | KAPA | Kairos Pharma, LTD. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -5.68 | 0.35 | 0.03 Bn |
| 250 | MDBH | MDB Capital Holdings, LLC | secondary | F-17 | Capital Markets | FG-05 | 0.03 Bn | -1.31 | — | 0.02 Bn |
| 251 | QCLS | Q/C Technologies, Inc. | secondary | T-01 | Semiconductors | TG-01 | 0.02 Bn | -2.05 | — | 0.02 Bn |
| 252 | RKTO | Rocket One Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.07 | — | 0.01 Bn |
| 253 | PBSV | Pharma-Bio Serv, Inc. | secondary | I-26 | Business Services | IG-06 | 0.01 Bn | 220.48 | 1.26 | 0.00 Bn |
| 254 | BFRG | BullFrog AI Holdings, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.62 | 28.60 | 0.00 Bn |
| 255 | INM | InMed Pharmaceuticals Inc. | secondary | M-02 | Chemicals | MG-01 | 0.01 Bn | -0.68 | — | 0.00 Bn |
| 256 | TPST | Tempest Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.27 | — | 0.00 Bn |
| 257 | BTAI | BioXcel Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.04 | 3.70 | 0.00 Bn |
| 258 | VIVS | VivoSim Labs, INC. | secondary | H-11 | Pharma Services | HG-03 | 0.00 Bn | -0.13 | 13.10 | 0.00 Bn |
| 259 | CPMV | Mosaic ImmunoEngineering Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.27 | — | 0.00 Bn |
| 260 | NOTVQ | Inotiv, Inc. | secondary | H-11 | Pharma Services | HG-03 | 0.00 Bn | 0.00 | 0.00 | -0.01 Bn |
| 261 | ZCMD | Zhongchao Inc. | secondary | T-27 | Vertical Software | TG-05 | 0.00 Bn | -0.01 | 0.00 | -0.01 Bn |